Skip to main content

Caliper and Johns Hopkins Recent Winners of US Patents

Premium

Caliper Life Sciences has been awarded US Patent No. 7,037,416, "Method for monitoring flow rate using fluorescent markers."

Inventors listed on the patent are Wallace Parce and Claudia Jaffe.

According to its abstract, the patent protects microfluidic methods, devices, and systems for monitoring and controlling flow rates in response to one or more marker signals. The marker signals are used to provide an indication of flow rate in the various channels of the devices. Signals obtained from the markers are deconvoluted and used in a feedback loop to make flow rate adjustments, the abstract states.


Johns Hopkins University has been awarded US Patent No. 7,037,648, "Somatic transfer of modified genes to predict drug effects."

Eduardo Marban is the sole inventor listed on the patent.

According to its abstract, the patent protects somatic cell gene transfer methods for mimicking one or more effects of a drug candidate compound. In one aspect, the methods mimic the effect of a drug candidate compound with potential to potentiate or suppress activity of a selected target molecule. In another aspect, the methods provide means of identifying a molecular target for the drug candidate compound. The present methods have a variety of uses including providing identified molecular targets for use in drug screens.

The Scan

Gap in COVAX Doses

BBC News reports that COVAX is experiencing a vaccine shortfall, as the Serum Institute of India has paused exports.

Sanofi, GSK Report Promising Results

The Wall Street Journal reports that the candidate SARS-CoV-2 vaccine from Sanofi and GlaxoSmithKline has had encouraging early results.

Influence of Luck

The New York Times examines how the US avoided variant-fueled increases in COVID-19 cases.

PLOS Papers on Retina GWAS, Hantaan Virus, COVID-19 Phenome-Wide Association Study

In PLOS this week: genome-wide association study of retinal morphology, analysis of hantaan virus found in a mouse, and more.